$PLUS

RAIGUEL DARREN S sold $91K of PLUS (indirect holdings)

RAIGUEL DARREN S (CHIEF OPERATING OFFICER) sold 1,000 indirectly-held shares of EPLUS INC (PLUS) at an average of $90.83 ($90.44–$91.09) across 2 trades on 2026-08-10 under a Rule 10b5-1 trading plan.

Original reporting
SEC EDGAR · RAIGUEL DARREN S
Published Aug 12, 2026, 8:38 PM UTC
Analysis
AlphAI AI DeskAI-generated
Added to AlphAI Aug 12, 2026, 8:44 PM UTC. Informational, not investment advice.
How this was made
AlphAI summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.
AlphAI market briefInsider activity
Primary signal
$PLUS
Neutral
medium confidence
Mentioned
$PLUS
Relevance
2/10
AlphAI data visualization · based on SEC EDGAR
Decision brief

The 30-second read

$PLUSNeutralLow
01

Why it matters

The disclosure provides a concrete datapoint on insider selling activity, but the pre-arranged nature and modest value reduce the likelihood of a fundamental re-rating catalyst.

02

Market read

Traders may log the insider sale for sentiment monitoring, but it is not a standalone fundamental catalyst.

03

What to watch

The sale is indirect and relatively small in dollar terms; without additional context (e.g., total insider activity trend), the signal-to-noise is limited.

Relevance 2/10Novelty 3/10Timing: filed 2026-08-12, transaction dated 2026-08-10

Background

The article is an SEC Form 4 insider transaction disclosure for EPLUS Inc (PLUS) by COO Raiguel Darren S, indicating an open-market sale under a Rule 10b5-1 plan.

Company-level read

Ticker impact

$PLUSNeutralMedium confidence
Context

EPLUS COO Raiguel Darren S sold about $90.8K of PLUS shares via a 10b5-1 plan, with 1,000 shares sold at $90.44 to $91.09 on 2026-08-10.

Expected impact

Low near-term impact; any reaction is likely limited to short-lived sentiment noise.

Evidence & confidence

The filing is a Form 4 insider transaction, but it explicitly states a pre-arranged 10b5-1 plan, which typically reduces interpretive value versus discretionary selling.

Market effects

No clear sector read-through from a small, 10b5-1 insider sale.

None indicated.

None indicated.

Counterpoint

Even with 10b5-1, repeated insider selling can coincide with internal expectations of near-term volatility or liquidity needs, so traders may still watch for follow-on sales.

Key entities

  • PLUS

    EPLUS Inc, issuer of the Form 4 insider transaction.

  • RAIGUEL DARREN S

    Chief Operating Officer of EPLUS Inc, reported an indirect open-market sale under a 10b5-1 plan.

Full insider trading history

This story covers one filing. See everything behind it: every insider buy and sell on record, 10b5-1 plans, late filings, and which officers and directors are trading.

Related articles

$CDWMedAI 8/10

Q2 Earnings Outperformers: CDW (NASDAQ:CDW) And The Rest Of The IT Distribution & Solutions Stocks

CDW, ePlus, TD SYNNEX, and ScanSource reported Q2 earnings. CDW (-6%) and ePlus (-10.5%) saw stock declines, while ScanSource (+5.5%) rose. TD SYNNEX (-10.5%) reported strong revenue growth but also fell. ePlus reported flat revenue but beat EPS estimates. ScanSource had the largest analyst estimate beat. TD SYNNEX reported $19.57B revenue, up 31% YoY, and beat EPS estimates and guidance.

$PLUSMed

Plus500 increases buybacks as US growth continues

Plus500 said it will increase shareholder returns via buybacks alongside its half-year results. The company reported double-digit revenue growth year over year and Ebitda up 1% to $188mn. It attributed a lower Ebitda margin (45% to 41%) to higher marketing spend to attract new customers, while expanding in US futures.

$PLUSMedAI 8/10

Why ePlus (PLUS) Shares Are Plunging Today

ePlus (NASDAQ: PLUS) shares fell about 5% after the company reported Q2 2026 results. Revenue rose 1.9% year over year to $649.1 million and adjusted EPS was $1.28, both above Wall Street estimates. Despite the beat, investors focused on declining adjusted operating and free cash flow margins and a forecast of about 2% full-year EPS growth. Shares later traded near $92.31.